It was a long run, but Merck’s Keytruda finally has some company in the previously untreated non-small cell lung cancer monotherapy department. Whether that company represents any real threat to its market share, however, remains to be seen. The FDA Monday green-lighted Roche’s Tecentriq on its own for newly diagnosed, metastatic patients without EGFR or… Read More »
FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers Print this page INDIANAPOLIS, May 8, 2020 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Retevmo™ (selpercatinib, 40 mg & 80 mg capsules), the first therapy specifically indicated for the treatment of adult patients with… Read More »
MONDAY, May 11, 2020 — Retevmo (selpercatinib) capsules have been approved to treat patients with non-small cell lung cancer (NSCLC), medullary thyroid cancer (MTC), and other thyroid cancers with an alteration in the “rearranged during transfection” (RET) gene, the U.S. Food and Drug Administration announced Friday. Retevmo was approved for adults with metastatic NSCLC and… Read More »
They often occur after a cold or flu. Brooks C, Pearce N, Douwes J. The same study showed that sinusitis coupled with asthma was more common in women than men. Below are relevant articles that asthma with lung infection interest you. Treatment with antibiotics is usually needed. Take an infusion, tincture, or syrup and combine… Read More »
Print this page 30 March 2020 — AstraZeneca’s Imfinzi (durvalumab) has been approved in the US as a 1st-line treatment for adult patients with extensive-stage small cell lung cancer (ES-SCLC) in combination with standard-of-care (SoC) chemotherapies, etoposide plus either carboplatin or cisplatin (platinum-etoposide). The approval by the Food and Drug Administration was based on positive results from… Read More »
FDA Approves Ofev (Nintedanib), For The Treatment of Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype Print this page March 09, 2020 — The U.S. Food and Drug Administration today approved Ofev (nintedanib) oral capsules to treat patients with chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait). It is the… Read More »